In January of 2020, Abcam acquired an experienced cell-engineering team from ASC to form the core engine of our in-house gene-editing capability, along with the AccuRef reference standards product line. We continue to actively invest in these and are pleased to announce that the team is moving to a new state-of-the-art facility, increasing our dedicated facility square footage by over 300%.
Our commitment to quality requires that we enforce a pause in production and shipping of the AccuRef standards range until all the necessary systems and processes are in place, and tested, in our new facility. This pause is scheduled to be for 12 weeks from 1st December 2020.
After this period, we anticipate our standard order fulfilment lead time will be in the order of 8-12 weeks. We appreciate that this might cause some disruption to a number of customers and if you are concerned please do contact us on email@example.com
Our Onco-Ref™ Custom FFPE Cell Block Services gives you the flexibilty to receive a custom FFPE product with high quality and consistency with a fast turnaround time at a great price. Simply ship us your cells. If needed, we can culture, fix the cells using buffered formalin (10% for 24hrs at room temperature, typically), and then prepare a cell core and embed the core into a paraffin block. If requested (optional), we can prepare FFPE Cell slides or FPPE Cell scrolls from a freshly prepared FFPE Cell Block. We typically turnaround a FFPE Cell block in 7 working days from receipt of 1 x 108 cells.
As a global life sciences company, Abcam identifies, develops, and distributes high-quality biological reagents and tools that are crucial to research, drug discovery and diagnostics. Working across the industry, the Company supports life scientists to achieve their mission, faster.
Abcam partners with life science organizations to co-create novel binders for use in drug discovery, in vitro diagnostics and therapeutics, driven by the Company's proprietary discovery platforms and world-leading, antibody expertise. By constantly innovating its binders and assays, Abcam is helping advance the global understanding of biology and causes of disease, which enables new treatments and improved health. The Company's pioneering data-sharing approach gives scientists increased confidence in their results by providing validation, user comments and peer-reviewed citations for its 110,000 products.
With eleven sites globally, many of Abcam's 1,100 strong team are located in the world's leading life science research hubs, complementing a global network of services and support. To find out more, please visit www.abcam.com and www.abcamplc.com.
AccuRef Diagnostics, a division of Applied StemCell Inc., is a global provider of molecular and cell-based reference standards used for assay development and quality control. With over 270 CRISPR-engineered mutation cell line variants we have created over 2,600 biologically-relevant quality control and reference standard products that spans 40+ cancer genes. Our Onco-Ref™ and Quan-Plex™ product lines offer single-mutation and quantitative multiplex gene panels, in easy-to-use formats such as gDNA, cell pellets, ctDNA, FFPE and cytopath slides.